| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-04-12 14:31:31 -0600 |
| HMDB ID |
HMDB00883 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
L-Valine |
| Description |
Valine (abbreviated as Val or V) is an -amino acid with the chemical formula HO2CCH(NH2)CH(CH3)2. It is named after the plant valerian. L-Valine is one of 20 proteinogenic amino acids. Its codons are GUU, GUC, GUA, and GUG. This essential amino acid is classified as nonpolar. Along with leucine and isoleucine, valine is a branched-chain amino acid. Branched chain amino acids (BCAA) are essential amino acids whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. "BCAA" denotes valine, isoleucine and leucine which are branched chain essential amino acids. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA)—tyrosine, tryptophan and phenylalanine, as well as methionine—are increased in these conditions. Valine in particular, has been established as a useful supplemental therapy to the ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. (http://www.dcnutrition.com). In sickle-cell disease, valine substitutes for the hydrophilic amino acid glutamic acid in hemoglobin. Because valine is hydrophobic, the hemoglobin does not fold correctly. Valine is an essential amino acid, hence it must be ingested, usually as a component of proteins. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (2S)-2-Amino-3-methylbutanoate
- (2S)-2-Amino-3-methylbutanoic acid
- (S)-2-amino-3-methyl-Butanoate
- (S)-2-amino-3-methyl-Butanoic acid
- (S)-2-Amino-3-methylbutanoate
- (S)-2-Amino-3-methylbutanoic acid
- (S)-2-Amino-3-methylbutyrate
- (S)-2-Amino-3-methylbutyric acid
- (S)-a-Amino-b-methylbutyrate
- (S)-a-Amino-b-methylbutyric acid
- (S)-alpha-Amino-beta-methylbutyrate
- (S)-alpha-Amino-beta-methylbutyric acid
- (S)-Valine
- 2-Amino-3-methylbutanoate
- 2-Amino-3-methylbutanoic acid
- 2-Amino-3-methylbutyrate
- 2-Amino-3-methylbutyric acid
- L-(+)-a-Aminoisovalerate
- L-(+)-a-Aminoisovaleric acid
- L-(+)-alpha-Aminoisovalerate
- L-(+)-alpha-Aminoisovaleric acid
- L-a-Amino-b-methylbutyrate
- L-a-Amino-b-methylbutyric acid
- L-alpha-Amino-beta-methylbutyrate
- L-alpha-Amino-beta-methylbutyric acid
- L-Valine
- Valine
|
| Chemical Formula |
C5H11NO2 |
| Average Molecular Weight |
117.1463 |
| Monoisotopic Molecular Weight |
117.078978601 |
| IUPAC Name |
(2S)-2-amino-3-methylbutanoic acid |
| Traditional IUPAC Name |
L-valine |
| CAS Registry Number |
72-18-4 |
| SMILES |
CC(C)[C@H](N)C(O)=O |
| InChI Identifier |
InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1 |
| InChI Key |
KZSNJWFQEVHDMF-BYPYZUCNSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Amino fatty acids(Lipidmaps)
- alpha-amino acid(ChEBI)
- branched-chain amino acid(ChEBI)
|
| Substituents |
- Carboxylic Acid
- Primary Aliphatic Amine (Alkylamine)
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Aminoacyl-tRNA biosynthesis
- Component of Valine, leucine and isoleucine biosynthesis
- Essential amino acids
|
| Application |
Not Available |
| Cellular locations |
- Extracellular
- Mitochondria
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
295 - 300 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
58.5 mg/mL |
Not Available |
| LogP |
-2.26 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 13C NMR Spectrum |
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Extracellular
- Mitochondria
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
212.3 +/- 61.3 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
266.3 +/- 61 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
233.0 (190.0-276.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
130.0 +/- 50.0 uM |
Newborn (0-30 days old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
232.0 +/- 28.0 uM |
Children (1-13 year old) |
Male |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
252.0 +/- 37.0 uM |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
209.0 +/- 31.0 uM |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
20.0 (10.0-30.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
19 +/- 13 uM |
Not Specified |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
15.0 +/- 2.8 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
23.8 +/- 4.5 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
23.9 +/- 6.9 uM |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
14.5 +/- 5.0 uM |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
18.1 +/- 10.1 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Saliva |
Detected and Quantified |
|
>10 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
5.5 (2.7-9.8) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by GC-MS
|
| Urine |
Detected and Quantified |
|
4.93 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
12.30 +/- 7.69 umol/mmol creatinine |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
<5.98-25.62 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.88 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Urine compound detected by GC-MS
|
| Urine |
Detected and Quantified |
|
0.0177 - 0.0353 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.15 +/- 1.49 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
4.3 (2.4-10.4) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by LC-MS/MS (Biocrates kit)
|
| Urine |
Detected and Quantified |
|
11.58 (8.51 – 15.04) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.4 (2.0-7.7) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
0.8 (0.3-1.35) umol/mmol creatinine |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.67 +/- 0.80 umol/mmol creatinine |
Children (1-13 year old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.0 +/- 1.0 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.3 +/- 1.2 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.355(1.118-5.592) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
144.2 +/- 61.4 uM |
Adult (>18 years old) |
Not Specified |
Heart Transplant |
Not Available |
| Blood |
Detected and Quantified |
|
81.0 +/- 122.0 uM |
Newborn (0-30 days old) |
Both |
Phenylketonuria (PKU) |
Not Available |
| Blood |
Detected and Quantified |
|
193.0 (184.0-201.0) uM |
Adult (>18 years old) |
Both |
Epilepsy |
Acute seizures
|
| Blood |
Detected and Quantified |
|
202.0 (194.0-209.0) uM |
Adult (>18 years old) |
Both |
Epilepsy |
Refractory localization-related epilepsy (RLE)
|
| Blood |
Detected and Quantified |
|
356.0 +/- 541.0 uM |
Newborn (0-30 days old) |
Both |
Maple syrup urine disease (MSUD) |
Not Available |
| Blood |
Detected and Quantified |
|
138.00 (86.00-190.0) uM |
Adult (>18 years old) |
Both |
Hypervalinemia |
Not Available |
| Blood |
Detected and Quantified |
|
1000.00 (500.00-1500.00) uM |
Adult (>18 years old) |
Both |
Hypervalinemia |
Not Available |
| Blood |
Detected and Quantified |
|
58.26 +/- 14.74 uM |
Elderly (>65 years old) |
Both |
Alzheimer's disease |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
98.61 uM(N=1) (Cachexia) Not Specified |
Adult (>18 years old) |
Not Specified |
Abnormal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
21.8 +/- 7.2 uM |
Children (1-13 year old) |
Not Specified |
Leukemia |
Acute Lymphoblastic Leukemia (ALL) with Central...
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
17.9 +/- 6.7 uM |
Children (1-13 year old) |
Not Specified |
Leukemia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
4.13 +/- 1.22 uM |
Adult (>18 years old) |
Both |
Alzheimer's disease |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
ADPKD |
Not Available |
| Urine |
Detected and Quantified |
|
3 (0-14) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Lung cancer |
Not Available |
| Urine |
Detected and Quantified |
|
15.49 (4.79 – 30.71) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Type 1 diabetes Mellitus |
Not Available |
| Urine |
Detected and Quantified |
|
0.73 +/- 0.12 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Alzheimer's disease |
Not Available |
| Urine |
Detected and Quantified |
|
15.8 (7.4-24.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Hypervalinemia |
Not Available |
| Urine |
Detected and Quantified |
|
118.4 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Hypervalinemia |
Not Available |
| Urine |
Detected and Quantified |
|
32.4 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Paraquat poisoning |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Abnormal |
- Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2008 Oct 25.
Pubmed: 18953024
|
| Phenylketonuria |
- Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.
Pubmed: 12101068
|
| Epilepsy |
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.
Pubmed: 14992292
|
| Maple syrup urine disease |
- Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.
Pubmed: 12101068
|
| Paraquat poisoning |
- Bairaktari E, Katopodis K, Siamopoulos KC, Tsolas O: Paraquat-induced renal injury studied by 1H nuclear magnetic resonance spectroscopy of urine. Clin Chem. 1998 Jun;44(6 Pt 1):1256-61.
Pubmed: 9625050
|
| Lung Cancer |
- Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2008 Oct 25.
Pubmed: 18953024
|
| Leukemia |
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.
Pubmed: 15911239
|
| Alzheimer's disease |
- Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.
Pubmed: 17031479
|
| Hypervalinemia |
- http://www.metagene.de/program/d.prg?mp=HYPERVALINEMIA
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
DB00161  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB000465 |
| KNApSAcK ID |
C00001398  |
| Chemspider ID |
6050  |
| KEGG Compound ID |
C00183  |
| BioCyc ID |
VAL  |
| BiGG ID |
34167  |
| Wikipedia Link |
valine  |
| NuGOwiki Link |
HMDB00883  |
| Metagene Link |
HMDB00883  |
| METLIN ID |
5842  |
| PubChem Compound |
6287  |
| PDB ID |
VAL  |
| ChEBI ID |
16414  |
| References |
| Synthesis Reference |
Kinoshita, Shukuo; Udaka, Shigezo. L-Valine production by fermentation. (1962), 2 pp. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.
Pubmed: 12101068
- Stickel F, Osterreicher CH, Datz C, Ferenci P, Wolfel M, Norgauer W, Kraus MR, Wrba F, Hellerbrand C, Schuppan D: Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Arch Intern Med. 2005 Sep 12;165(16):1835-40.
Pubmed: 16157826
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.
Pubmed: 15911239
- Wudy SA, Hartmann M, Solleder C, Homoki J: Determination of 17alpha-hydroxypregnenolone in human plasma by routine isotope dilution mass spectrometry using benchtop gas chromatography-mass selective detection. Steroids. 2001 Oct;66(10):759-62.
Pubmed: 11522338
- Szpetnar M, Pasternak K, Boguszewska A: Branched chain amino acids (BCAAs) in heart diseases (ischaemic heart disease and myocardial infarction). Ann Univ Mariae Curie Sklodowska [Med]. 2004;59(2):91-5.
Pubmed: 16146056
- Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6.
Pubmed: 12297216
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.
Pubmed: 14992292
- Bairaktari E, Katopodis K, Siamopoulos KC, Tsolas O: Paraquat-induced renal injury studied by 1H nuclear magnetic resonance spectroscopy of urine. Clin Chem. 1998 Jun;44(6 Pt 1):1256-61.
Pubmed: 9625050
- Hongpaisan J: Inhibition of proliferation of contaminating fibroblasts by D-valine in cultures of smooth muscle cells from human myometrium. Cell Biol Int. 2000;24(1):1-7.
Pubmed: 10826768
- Wevers RA, Engelke U, Wendel U, de Jong JG, Gabreels FJ, Heerschap A: Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem. 1995 May;41(5):744-51.
Pubmed: 7729054
- Deligezer U, Akisik EE, Dalay N: Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo. 2005 Sep-Oct;19(5):889-93.
Pubmed: 16097444
- Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7.
Pubmed: 12097436
- Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.
Pubmed: 2026685
- McInturff JE, Wang SJ, Machleidt T, Lin TR, Oren A, Hertz CJ, Krutzik SR, Hart S, Zeh K, Anderson DH, Gallo RL, Modlin RL, Kim J: Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J Invest Dermatol. 2005 Aug;125(2):256-63.
Pubmed: 16098035
- Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH: Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J. 1984 Jan 15;217(2):365-75.
Pubmed: 6696735
- Jensen PK, Jacobsen NO: Studies of D-amino acid oxidase activity in human epidermis and cultured human epidermal cells. Arch Dermatol Res. 1984;276(1):57-64.
Pubmed: 6142701
- Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7.
Pubmed: 6198473
- Kurpad AV, Regan MM, Raj TD, Gnanou JV, Rao VN, Young VR: The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach. Am J Clin Nutr. 2005 Aug;82(2):373-9.
Pubmed: 16087981
|